Clinical Evaluation of Individualized and Navigated Microsecond Pulsing Laser for Acute Central Serous Chorioretinopathy.
Ophthalmic Surg Lasers Imaging Retina
; 51(9): 512-520, 2020 09 01.
Article
em En
| MEDLINE
| ID: mdl-32955591
ABSTRACT
BACKGROUND AND OBJECTIVE:
A computational model has predicted parameters for using a navigated microsecond pulsing laser system to treat central serous chorioretinopathy (CSC). PATIENTS ANDMETHODS:
A prospective, single-center, interventional case series was conducted for patients with acute CSC who were enrolled following screening and informed consent. Treatment involved laser pulse duration of 50 µs, 2.4% Duty Cycle, 100 µm spot size, and 10 ms pulse duration.RESULTS:
Average best-corrected visual acuity (decimal) of 12 patients improved from 0.86 ± 0.03 at baseline to 0.97 ± 0.01 at 3 months. Baseline central retinal thickness decreased from 452.58 µm ± 24.53 µm at baseline to 249.25 µm ± 2.92 µm at 3 months. Retinal sensitivity improved from 24.1 dB ± 1.09 dB at baseline to 28.98 dB ± 0.23 dB at 3 months. In all cases, subretinal fluid was resorbed.CONCLUSION:
The parameter sets derived from the computer model can be applied safely and effectively for CSC treatment using the navigated microsecond pulsing laser system. [Ophthalmic Surg Lasers Imaging Retina. 2020;51512-520.].
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
Base de dados:
MEDLINE
Assunto principal:
Retina
/
Acuidade Visual
/
Fotocoagulação a Laser
/
Coriorretinopatia Serosa Central
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ophthalmic Surg Lasers Imaging Retina
Ano de publicação:
2020
Tipo de documento:
Article